-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CYp6nL0+Qgk7trjHe2IQdedUxUpf07W3/2ftrrr6+CSxstlPDZqxeNIsOd2HLs8+ WKAdPKcKp9kIwAdrE0/Clg== 0001324517-06-000043.txt : 20060719 0001324517-06-000043.hdr.sgml : 20060719 20060719151835 ACCESSION NUMBER: 0001324517-06-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060717 FILED AS OF DATE: 20060719 DATE AS OF CHANGE: 20060719 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLES N ANTHONY CENTRAL INDEX KEY: 0001197018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 06969317 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-07-17 0000890465 NPS PHARMACEUTICALS INC NPSP 0001197018 COLES N ANTHONY 383 COLOROW DRIVE SALT LAKE CITY UT 84108 1 1 0 0 CEO, President and Director Stock Option 4.07 2006-07-17 4 A 0 22500 0 A 2007-07-17 2016-07-17 Common Stock 22500 22500 D Granted under the 2005 Omnibus Incentive Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter. Kevin J. Ontiveros 2006-07-19 -----END PRIVACY-ENHANCED MESSAGE-----